B-PRECURSOR ALL
Clinical trials for B-PRECURSOR ALL explained in plain language.
Never miss a new study
Get alerted when new B-PRECURSOR ALL trials appear
Sign up with your email to follow new studies for B-PRECURSOR ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells show promise against hard-to-treat childhood blood cancers
Disease control CompletedThis study tested a new treatment for children and young adults (ages 1-39) with B-cell leukemia or lymphoma that did not respond to standard therapy. Researchers took participants' white blood cells, modified them in a lab to target the CD22 protein on cancer cells, and infused …
Matched conditions: B-PRECURSOR ALL
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 11:02 UTC
-
New combo therapy shows promise for older leukemia patients
Disease control CompletedThis study tested a new treatment plan for adults aged 55-75 with a specific type of leukemia (B-precursor ALL). The approach uses a reduced dose of chemotherapy followed by a targeted drug called blinatumomab. The goal was to achieve remission while reducing harsh side effects. …
Matched conditions: B-PRECURSOR ALL
Phase: PHASE2 • Sponsor: Goethe University • Aim: Disease control
Last updated May 26, 2026 10:35 UTC